We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.11 | 1.20% | 9.25 | 9.00 | 9.50 | 9.25 | 9.25 | 9.25 | 1,064,455 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.67 | 16.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/4/2024 09:45 | morning gerbys glorious PING today | thanatos abysss | |
29/4/2024 09:32 | Actually that would be very prudent. Excellent suggestion | institutional investments | |
29/4/2024 09:27 | Maybe prudent to wait to see if there are no more mugs in the pipeline before lowering the share price ? Perhaps he has another 75k to shift | kreature | |
29/4/2024 09:10 | just looking at the dumping elsewhere off L2, like 75000 at 1627 on Friday, and ask myself, how has the maker this priced at 9p today? | institutional investments | |
28/4/2024 11:35 | If not sure how to, SYME has a great 10 year course on offer, via financials and podcasts | thanatos abysss | |
28/4/2024 10:47 | If not sure how to, OPTI has a great 10 year course on offer, via financials and podcasts | institutional investments | |
28/4/2024 10:45 | Expect normal operational losses to be maintained or increase next time around Probably best to get the next one 'out of the way' and focus on the one after, with great imagination and podcasts | institutional investments | |
28/4/2024 10:42 | Probably means costs will match plus extra cash extraction acquisitions and other methodologies to be added to de-risk? | institutional investments | |
28/4/2024 10:41 | Was just looking at some software forward projections out there. So estimated Revenues to rise, of course yet cashflow from operations to get worse. No movement on EPS estimates, normalized net income to be worse. List goes on have the analysts started to figure out what headline mega revenue rises means for opti, sbtx and pbx? | institutional investments | |
28/4/2024 08:06 | Certainly seems very binary here imv | kreature | |
28/4/2024 08:04 | But the dandruff is still there | whats my name | |
28/4/2024 08:03 | Seems to be a massive head and shoulders on the monthly | whats my name | |
28/4/2024 08:02 | Seems like a dilemma…… | kreature | |
28/4/2024 07:59 | Skinbiotics.co.uk has all but flushed skinbiotiX down the toilet with bleach in my opinion anyway | kreature |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions